Sherif A - Search Results

1

Neoadjuvant cisplatinum based combination chemotherapy in patients with invasive bladder cancer: a combined analysis of two Nordic studies.

Sherif A, Holmberg L, Rintala E, Mestad O, Nilsson J, Nilsson S, Malmström PU; Nordic Urothelial Cancer Group. Sherif A, et al. Eur Urol. 2004 Mar;45(3):297-303. doi: 10.1016/j.eururo.2003.09.019. Eur Urol. 2004. PMID: 15036674

2

Lymphatic mapping and detection of sentinel nodes in patients with bladder cancer.

Sherif A, De La Torre M, Malmström PU, Thörn M. Sherif A, et al. J Urol. 2001 Sep;166(3):812-5. J Urol. 2001. PMID: 11490224

3

Early metastatic progression of bladder carcinoma: molecular profile of primary tumor and sentinel lymph node.

Malmström PU, Ren ZP, Sherif A, de la Torre M, Wester K, Thörn M. Malmström PU, et al. Among authors: sherif a. J Urol. 2002 Nov;168(5):2240-4. doi: 10.1016/S0022-5347(05)64363-7. J Urol. 2002. PMID: 12394767

4

Neoadjuvant cisplatin-methotrexate chemotherapy for invasive bladder cancer -- Nordic cystectomy trial 2.

Sherif A, Rintala E, Mestad O, Nilsson J, Holmberg L, Nilsson S, Malmström PU; Nordic Urothelial Cancer Group. Sherif A, et al. Scand J Urol Nephrol. 2002;36(6):419-25. doi: 10.1080/003655902762467567. Scand J Urol Nephrol. 2002. PMID: 12623505 Clinical Trial.

5

Re: extended radical lymphadenectomy in patients with urothelial bladder cancer: results of a prospective multicenter study.

Malmström PU, Sherif A, Thörn M. Malmström PU, et al. Among authors: sherif a. J Urol. 2004 Jul;172(1):386; author reply 386. doi: 10.1097/01.ju.0000132366.20760.53. J Urol. 2004. PMID: 15201817 No abstract available.

6

Detection of immune responses against urinary bladder cancer in sentinel lymph nodes.

Marits P, Karlsson M, Sherif A, Garske U, Thörn M, Winqvist O. Marits P, et al. Among authors: sherif a. Eur Urol. 2006 Jan;49(1):59-70. doi: 10.1016/j.eururo.2005.09.010. Epub 2005 Nov 14. Eur Urol. 2006. PMID: 16321468

7

Hybrid SPECT-CT: an additional technique for sentinel node detection of patients with invasive bladder cancer.

Sherif A, Garske U, de la Torre M, Thörn M. Sherif A, et al. Eur Urol. 2006 Jul;50(1):83-91. doi: 10.1016/j.eururo.2006.03.002. Epub 2006 Mar 20. Eur Urol. 2006. PMID: 16632191

8

Chemotherapy for bladder cancer: treatment guidelines for neoadjuvant chemotherapy, bladder preservation, adjuvant chemotherapy, and metastatic cancer.

Sternberg CN, Donat SM, Bellmunt J, Millikan RE, Stadler W, De Mulder P, Sherif A, von der Maase H, Tsukamoto T, Soloway MS. Sternberg CN, et al. Among authors: sherif a. Urology. 2007 Jan;69(1 Suppl):62-79. doi: 10.1016/j.urology.2006.10.041. Urology. 2007. PMID: 17280909 Review.

9

Treatment of muscle-invasive bladder cancer.

Sherif A, Jonsson MN, Wiklund NP. Sherif A, et al. Expert Rev Anticancer Ther. 2007 Sep;7(9):1279-83. doi: 10.1586/14737140.7.9.1279. Expert Rev Anticancer Ther. 2007. PMID: 17892428 Review.

10

Current status of prognostic immunohistochemical markers for urothelial bladder cancer.

Rosenblatt R, Jonmarker S, Lewensohn R, Egevad L, Sherif A, Kälkner KM, Nilsson S, Valdman A, Ullén A. Rosenblatt R, et al. Among authors: sherif a. Tumour Biol. 2008;29(5):311-22. doi: 10.1159/000170878. Epub 2008 Nov 5. Tumour Biol. 2008. PMID: 18984977 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

557 results

Search Page

Filters